Abstract: According to an aspect of the invention, there is provided a low back pain analysis device comprising: a processor; and a storage medium having computer program instructions stored thereon, wherein the computer program instructions, when executed by the processor, perform processing of: obtaining a relationship between a result of a pattern and a low back pain, using the result of the pattern obtained by classifying gravity center movement data acquired by a sensor, which is attached to furniture and acquires the gravity center movement data for a sitting period including a period for which a person is sitting on the furniture, using clustering.

Abstract: A heatstroke prevention device includes an auricle temperature sensor configured to measure an auricle temperature that is a temperature of an auricle of a biological body; a controller configured to determine a possibility of development of heatstroke of the biological body on the basis of the auricle temperature; and a notification means configured to give a notice that there is the possibility of the development of the heatstroke on the basis of a determination result of the controller. The controller includes a comparison unit configured to compare the measured auricle temperature and a preset threshold of the auricle temperature, and to determine whether there is the possibility of the development of the heatstroke on the basis of a comparison result, and an operation control unit configured to control operation of the notification means on the basis of a determination result of the comparison unit.

Abstract: A master device transmits received image data to a mobile phone terminal and includes a storage unit that stores sensor setting information including at least sensitivity or a threshold value of a sensor, the mobile phone terminal includes a display and input unit, displays the image data transmitted from the master device on the display and input unit, requests the master device to provide the sensor setting information when receiving a predetermined operation, displays the sensor setting information transmitted from the master device on the display and input unit, and transmits the changed sensor setting information to the master device when receiving an operation of changing the sensor setting information, and the master device updates the sensor setting information stored in the storage unit using the sensor setting information after changing transmitted from the mobile phone terminal.

Abstract: A novel angiogenesis inhibitor, and a method for inhibiting angiogenesis are provided. Also provided are a prophylactic or therapeutic agent for a disease accompanied by angiogenesis, and a method for preventing or treating a disease accompanied by angiogenesis. The angiogenesis inhibitor contains L-carbocisteine or a pharmaceutically acceptable salt thereof as an active ingredient.

Abstract: A master device transmits received image data to a mobile phone terminal and includes a storage unit that stores sensor setting information including at least sensitivity or a threshold value of a sensor, the mobile phone terminal includes a display and input unit, displays the image data transmitted from the master device on the display and input unit, requests the master device to provide the sensor setting information when receiving a predetermined operation, displays the sensor setting information transmitted from the master device on the display and input unit, and transmits the changed sensor setting information to the master device when receiving an operation of changing the sensor setting information, and the master device updates the sensor setting information stored in the storage unit using the sensor setting information after changing transmitted from the mobile phone terminal.

Abstract: A novel angiogenesis inhibitor, and a method for inhibiting angiogenesis are provided. Also provided are a prophylactic or therapeutic agent for a disease accompanied by angiogenesis, and a method for preventing or treating a disease accompanied by angiogenesis. The angiogenesis inhibitor contains L-carbocisteine or a pharmaceutically acceptable salt thereof as an active ingredient.

Abstract: An object of the present invention is to provide a process, or the like, suitable for the industrialization of effective deprotection reaction without using a toxic solvent as well as to provide a process, or the like, for preparing a water-soluble azole prodrug effectively. The present invention provides a process for preparing a salt represented by Formula (I); (wherein X represents a fluorine atom bonded at position 4 or position 5 of a phenyl group) comprising the steps of: (a) carrying out a deprotection reaction of a compound represented by Formula (II); (wherein X represents a fluorine atom bonded at position 4 or position 5 of a phenyl group) in the presence of a carbocation scavenger.

Abstract: The present invention provides the compound of formula (I) in a solid form which, as a bulk medicament for pharmaceutical manufacture, is uniform, has a high purity, and is easy to work with. The invention further provides a process for preparing this compound, and pharmaceutical compositions containing the same. A solid form of (8E,12E,14E)-7-{(4-cycloheptylpiperazin-1-yl)carbonyl}oxy-3,6,16,21-tetrahydroxy-6,10,12,16,20-pentamethyl-18,19-epoxytricosa-8,12,14-trien-11-olide which has uniform specifications and is easy to work with was developed.

Abstract: Disclosed is a commercially advantageous method for producing a pyrazole fused ring derivative (such as a 7-phenylpyrazolo[1,5-a]pyridine derivative).

Abstract: The present invention provides a process or the like which is employed for producing chloromethyl phosphate derivatives that are useful for producing water-soluble prodrugs, and which are excellent from the points of view of workability, operativity and energy saving. According to the present invention, there is provided a process for producing a composition containing a compound represented by the following formula (I) and a tertiary amine, (wherein R1 and R2 are identical or different from each other, and represent a C1-C6 alkyl group, a C2-C6 alkenyl group or a C6-C14 aryl C1-C6 alkyl group which may have a substituent, and R1 and R2 may together form a ring), the process comprising the step of adding the tertiary amine having a boiling point at 1 atmosphere of 150° C. or higher to the compound represented by formula (I).

Abstract: An electronic data storage system stores electronic data with attaching an electronic signature, and output the electronic data along with the attached electronic signature, which decreases the operation costs with a simple operation. By using a public key-based signature, a third party can verify the data, and by using a secret check code, the electronic signature at registration is always valid without risk of falsification. Also by attaching an electronic signature at access, the validity of the stored data is assured, and a third party can verify the data. By using all of these features, the verification by a third party becomes possible over the long term. In this way the long term storage of electronic data is implemented.

Abstract: An object of the present invention is to provide a process, or the like, suitable for the industrialization of effective deprotection reaction without using a toxic solvent as well as to provide a process, or the like, for preparing a water-soluble azole prodrug effectively. The present invention provides a process for preparing a salt represented by Formula (I); (wherein X represents a fluorine atom bonded at position 4 or position 5 of a phenyl group) comprising the steps of: (a) carrying out a deprotection reaction of a compound represented by Formula (II); (wherein X represents a fluorine atom bonded at position 4 or position 5 of a phenyl group) in the presence of a carbocation scavenger.

Abstract: Discloses is a process for producing ?-D-glucopyranose, 3-O-decyl-2-deoxy-6-O-[2-deoxy-3-O-[(3R)-3-methoxydecyl]-6-O-methyl-2-[(11Z)-1-oxo-11-octadecenyl]amino]-4-O-phosphono-?-D-glucopyranosyl]-2-[(1,3-dioxotetradecyl)amino]- or 1-(dihydrogen phosphate) tetrasodium salt which is useful as an active ingredient of a pharmaceutical or an intermediate for the synthesis thereof, which is environment-friendly and excellent in safety, operationality and reproducibility. A process for producing a compound represented by the formula (I) comprising the steps of reacting a compound represented by the formula (VIII) with a palladium catalyst in the presence of a nucleopholic agent and treating the product with a sodium source.

Abstract: The present invention provides the compound of formula (I) in a solid form which, as a bulk medicament for pharmaceutical manufacture, is uniform, has a high purity, and is easy to work with. The invention further provides a process for preparing this compound, and pharmaceutical compositions containing the same. A solid form of (8E,12E,14E)-7-{(4-cycloheptylpiperazin-1-yl)carbonyl}oxy-3,6,16,21-tetrahydroxy-6,10,12,16,20-pentamethyl-18,19-epoxytricosa-8,12,14-trien-11-olide which has uniform specifications and is easy to work with was developed.

Abstract: To make it possible, even for each of general users who is not familiar with the setting of an IP network, to automatically connect to and communicate with an apparatus within a firewall from the outside of the firewall without changing the setting of the firewall, a personal computer PC 2 generates a temporal IP address, then the PC 2 sends a notification to an unspecified number of partner-side apparatuses by the broadcasting transmission so as to set the temporal IP address thus generated, then a communication terminal 3a sets the IP address thus notified as a temporal address in place of the original IP address of the own communication terminal.

Abstract: An electronic data storage system stores electronic data with attaching an electronic signature, and output the electronic data along with the attached electronic signature, which decreases the operation costs with a simple operation. By using a public key-based signature, a third party can verify the data, and by using a secret check code, the electronic signature at registration is always valid without risk of falsification. Also by attaching an electronic signature at access, the validity of the stored data is assured, and a third party can verify the data. By using all of these features, the verification by a third party becomes possible over the long term. In this way the long term storage of electronic data is implemented.

Abstract: When a sweeping process and a backup process are performed on an electronic library file in an electronic library, a file storing a history of the sweeping process or a history of a backup process is generated, and the sweeping and the backup processes are managed. Thus, a user can easily manage as to which medium an original document has been swept to or where a backup copy of the original document is. If the uniqueness of the original document shown in a sweep history and a backup history can be secured, the problem that there can be a plurality of original documents on the storage media of a plurality of electronic libraries can be avoided.

Abstract: A phenothiazine, acridan, acridone oxime, acridone hydrazone and dibenzodiazepine derivative represented by formula (I) effective against diseases in which histamine, leukotrienes, etc. participate and effective in preventing or treating diseases in which chemical mediators such as histamine and leukotrienes participate, for example, asthma, allergic rhinitis, atopic dermatitis, urticaria, hay fever, gastrointestinal allergy and food allergy.

Abstract: The present invention provides a communication control system that includes a control terminal having a display unit for displaying an image and a controlled computer, and transmits image information stored in the computer to the terminal. The terminal transmits image display capability information of the terminal, and the computer then receives it. The computer processes the image information of the computer based on the image display capability information of the terminal, and transmits it to the terminal. The terminal receives the changed image information and displays it on the display unit. This process allows efficient communication. When such control is stored as a program in a storage medium, a general computer can be controlled.

Abstract: A phenothiazine, acridan, acridone oxime, acridone hydrazone and dibenzodiazepine derivative represented by formula (I) 1